By Professor Yong Li

Journal articles

You J; Cozzi PJ; Walsh B; Willcox MD; Kearsley J; Russell PJ; Li Y, 2010, 'Innovative biomarkers for prostate cancer early diagnosis and progression', Critical Reviews in Oncology Hematology, 73, pp. 10 - 22, http://dx.doi.org/10.1016/j.critrevonc.2009.02.007

You J; Fitzgerald A; Cozzi PJ; Zhao Z; Graham PH; Russell PJ; Walsh B; Willcox MD; Ling Z; Wasinger VC; Li Y, 2010, 'Post-translation modification of proteins in tears', Electrophoresis, 31, pp. 1853 - 1861, http://dx.doi.org/10.1002/elps.200900755

You J; Fitzgerald A; Cozzi PJ; Zhao Z; Graham P; Russell PJ; Walsh BJ; Willcox M; Zhong L; Wasinger V; Li Y, 2010, 'Post‐translation modification of proteins in tears', PROTEOMICS – Clinical Applications, 4, pp. 870 - 870, http://dx.doi.org/10.1002/prca.201090087

Li Y; Cozzi PJ; Russell P, 2010, 'Promising tumor-associated antigens for future prostate cancer therapy', Medicinal Research Reviews, 30, pp. 67 - 101

Madigan M; Kingsley E; Paul C; Delprado W; Russell P; Li Y, 2009, 'The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression', CLINICAL & EXPERIMENTAL METASTASIS, 26, pp. 898 - 898, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000271722300160&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chen H; Hao J; Wang L; Li Y, 2009, 'Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression', British Journal of Cancer, 101, pp. 432 - 440

Wang LL; Madigan MC; Chen H; Liu F; Patterson K; Beretov J; O Brien P; Li Y, 2009, 'Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients', Gynecologic Oncology, 114, pp. 265 - 272

Li Y; Song YE; Rizvi SM; Power C; Beretov J; Raja C; Cozzi PJ; Morgenstern A; Apostolidis C; Allen BJ; Russell PJ, 2009, 'Inhibition of Micrometastatic Prostate Cancer Cell Spread in Animal Models By (213)Bilabeled Multiple Targeted alpha Radioimmunoconjugates', Clinical Cancer Research, 15, pp. 865 - 875, http://dx.doi.org/10.1158/1078-0432.CCR-08-1203

Kearsley J; Cozzi PJ; Li Y, 2008, 'Overview of Tumor-Associated Antigens (TAAs) as potential Therapeutic Targets for prostate Cancer Therapy', Current Cancer Therapy Reviews, 4, pp. 271 - 284

Rizvi SM; Qu CF; Raja C; Yuen J; Li Y; Morgenstern A; Apostolidis C; Allen BJ; Song YE, 2008, 'The cytokinesis-block micronucleus assay as a biological dosimeter for targeted alpha therapy', Physics in Medicine and Biology, 53, pp. 319 - 328, http://dx.doi.org/10.1088/0031-9155/53/2/001

Madigan MC; Kingsley EA; Cozzi PJ; Delprado W; Russell PJ; Li Y, 2008, 'The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression', Cancer Immunology and Immunotherapy, 57, pp. 1367 - 1379

Wang L; Ma J; Liu F; Yu Q; Chu G; Perkins A; Li Y, 2007, 'Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance', Gynecologic Oncology, 105, pp. 695 - 702

Li Y; Cozzi PJ, 2007, 'MUC1 is a promising therapeutic target for prostate cancer therapy', Current Cancer Drug Targets, 7, pp. 259 - 271

Allen B; Raja C; Rizvi S; Song E; Li Y; Graham P; Kearsley J; Thompson J; Morgenstern A; Apostolidis C; Reisfeld R, 2007, 'P-16 Regression of melanoma by tumour anti-vascular alpha therapy', Melanoma Research, 17, pp. A24 - A24, http://dx.doi.org/10.1097/00008390-200702000-00062

Li Y; Cozzi PJ, 2007, 'Targeting uPA/uPAR in prostate cancer', Cancer Treatment Reviews, 33, pp. 521 - 527

Wang JQ; Abbas Rizvi SM; Madigan MC; Cozzi PJ; Morgenstern A; Qu CF; Apostolidis C; Russell PJ; Allen BJ; Li Y, 2006, 'Control of prostate cancer spheroid growth using (213)Bi-labeled multiple targeted alpha radioimmunoconjugates', Prostate, 66, pp. 1753 - 1767

Wang J; Rizvi SM; Madigan MC; Cozzi PJ; Power C; Qu CF; Morgenstern A; Apostolidis C; Russell PJ; Allen BJ; Li Y, 2006, 'Control of prostate cancer spheroid growth using 213Bi-labeled multiple targeted alpha radioimmunoconjugates.', Prostate, 66, pp. 1753 - 1767

Song YE; Qu CF; Rizvi SM; Li Y; Robertson G; Raja C; Morgenstern A; Apostolidis C; Perkins A; Allen BJ, 2006, 'Cytoxicity of PA12, C595 and Herceptin vectors labeled with the alpha-emitting radioisotope Bismuth-213 for ovarian cancer cell monolayers and clusters', Cancer Letters, 234, pp. 176 - 183

Cozzi PJ; Wang JQ; Delprado W; Madigan MC; Fairy S; Russell PJ; Li Y, 2006, 'Evaluation of urokinase plasminogen activator and its receptor in different grades of human prostate cancer', Human Pathology, 37, pp. 1442 - 1451

Rizvi SM; Li Y; Song YE; Qu CF; Raja C; Morgenstern A; Apostollidis C; Allen BJ, 2006, 'Preclinical studies of Bismuth-213 labeled plasminogen activator inhibitor type 2 (PAI2) in a prostate cancer nude mouse xenograft model', Cancer Biology and Therapy, 5, pp. 386 - 393

Nielsen A; Scarlett CJ; Samra JS; Gill A; Li Y; Allen BJ; Smith RC, 2005, 'Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 20, pp. 256 - 263, http://dx.doi.org/10.1111/j.1440-1746.2004.03531.x

Qu CF; Songl YJ; Rizvi SMA; Li Y; Smith R; Perkins AC; Morgenstern A; Brechbiel M; Allen BJ, 2005, 'In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using 213Bi-CHX.A"-C595.', Cancer biology & therapy, 4, pp. 848 - 853, http://dx.doi.org/10.4161/cbt.4.8.1892

Nielsen A; Scarlett CJ; Samra JS; Gill A; Li Y; Allen BJ; Smith RC, 2005, 'Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction', Journal of Gastroenterology and Hepatology (Australia), 20, pp. 256 - 263, http://dx.doi.org/10.1111/j.1440-1746.2004.03531.x

Zhang D; Li Y; Rizvi SM; Qu CF; Kearsley J; Allen BJ, 2005, 'Cytotoxicity of breast cancer cells overexpressing HER2/neu by(213)Bi-Herceptin radioimmunoconjugate', Cancer Letters, 218, pp. 181 - 190

Cozzi PJ; Rizvi SM; Wang J; Qu CF; Allen BJ; Li Y, 2005, 'Expression of membrane-bound uPA in human prostate cancer cells for in vitro and in vivo targeted alpha therapy using 213Bi-PAI2 alpha emitting radioconjugate', British Journal of Urology, 95, pp. 16 - 17

Li Y; Wang JQ; Rizvi SM; Conway RM; Billson FA; Allen BJ; Madigan MC, 2005, 'In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells', Investigative Ophthalmology and Visual Science, 46, pp. 4365 - 4371

Qu CF; Song YE; Rizvi SM; Li Y; Smith RC; Perkins A; Morgenstern A; Brechbiel M; Allen BJ, 2005, 'In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using Bi-213-CHX.A`-C595', Cancer Biology and Therapy, 4, pp. 848 - 853

Allen BJ; Raja C; Rizvi SM; Tsui WW; Li Y; Graham PH; Thompson J; Reisfeld RA; Kearsley J; Morgenstern A; Apostolidis C, 2005, 'Intralesional targeted alpha therapy for metastatic melanoma', Cancer Biology and Therapy, 4, pp. 1318 - 1324

Cozzi PJ; Wang J; Delprado W; Perkins A; Allen BJ; Russell PJ; Li Y, 2005, 'MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer', Clinical and Experimental Metastasis, 22, pp. 565 - 573

Qu CF; Li Y; Rizvi SM; Raja C; Smith RC; Morgenstern A; Apostolidis C; Allen BJ; Song YE, 2005, 'Pre-clinical study of Bi-213 labeled PAI2 for the control of micrometastatic pancreatic cancer', Clinical and Experimental Metastasis, 22, pp. 575 - 586

Li Y; Rizvi SM; Blair JM; Cozzi PJ; Chang QF; Kim OT; Tam P; Perkins A; Russell PJ; Allen BJ, 2004, 'Antigenic Expression of Human Metastatic Prostate Cancer Cell Lines for In Vitro Multiple-Targetes A-Therapy with 21Bi-Conjugates', International Journal of Radiation Oncology and Biology Physics, 60, pp. 896 - 908

Li Y; Russell PJ; Allen BJ, 2004, 'Cytotoxicity of human prostate cancer cell lines in vitro and induction of apoptosis using 213Bi-Herceptin alpha-conjugate', Cancer Letters, 205, pp. 161 - 171

Russell PJ; Ow KT; Tam P; Juarez J; Kingsley EA; Li Y; Cozzi PJ; Qu CF; Martiniello-Wilks R, 2004, 'Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancer', Cancer Immunology and Immunotherapy, 53, pp. 995 - 1004

Qu CF; Song YE; Rizvi SM; Raja C; Zhang D; Samra J; Smith R; Perkins A; Apostolidis C; Allen BJ, 2004, 'MUC-1 expression in primary and metastatic [ancreatic cancer cells for in vitro treatment by 213 Bi-C595 radioimmunoconjugate', British Journal of Cancer, 91, pp. 2086 - 2093

Allen BJ; Raja C; Rizvi SM; Li Y; Tsui WW; Zhang DY; Song YE; Qu CF; Kearsley J; Graham PH; Thompson J, 2004, 'Targeted alpha therapy for cancer', Physics in Medicine and Biology, 49, pp. 3703 - 3712

Li Y; Russell PJ; Allen BJ, 2004, 'Targeted alpha-therapy for control of micrometastatic prostate cancer', Expert Review of Anticancer Therapy, 4, pp. 459 - 468, http://www.sciencedirect.com/science/article/B6WVB-4CGGB79-1Y2/2/78aed94232955f13edd392636a9f091a

Allen BJ; Tian Z; Rizvi SMA; Li Y; Ranson M, 2003, 'Preclinical studies of targeted α therapy for breast cancer using ²¹³Bi-labelled-plasminogen activator inhibitor type 2', British Journal of Cancer, 88, pp. 944 - 950, http://dx.doi.org/10.1038/sj.bjc.6600838

Li L; Li Y; Krilis S; Qi JC; Moore CH; Madigan MC; Katsoulotos GP, 2003, 'An antibody raised against in-vitro-derived human mast cells identifies mature mast cells and a population of cells that are Fc...., Tryptase, and chymase in a variety of human tissues', Journal of Histochemistry and Cytochemistry, 51, pp. 643 - 653

Li Y; Madigan MC; Conway RM; Billson FA; Crouch RL; Allen BJ, 2003, 'Human uveal melanoma expresses NG2 immunoreactivity', British Journal of Ophthalmology, 87, pp. 629 - 632

Rizvi SM; Li Y; Raja C; Allen BJ, 2003, 'In vitro and preclinical testing of Bi-213 labeled antimelanoma monoclonal antibody 9.2.27', Abstracts of Papers of the American Chemical Society, 225, pp. U261 - U261

Li Y; Rizvi SMA; Ranson M; Allen BJ, 2002, 'Bi-213-PAI2 conjugate selectively induces apoptosis in PC3 metastatic prostate cancer cell line and shows anti-cancer activity in a xenograft animal model', BRITISH JOURNAL OF CANCER, 86, pp. 1197 - 1203, http://dx.doi.org/10.1038/sj/bjc/6600179

Li Y; Tian Z; Rizvi SMA; Bander NH; Allen BJ, 2002, 'In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen', Prostate Cancer and Prostatic Diseases, 5, pp. 36 - 46, http://dx.doi.org/10.1038/sj.pcan.4500543

Allen BJ; Tian Z; Li Y; Andronicos NJ; Rizvi S; Ranson M, 2001, 'In vitro and preclinical studies of targeted alpha therapy for human breast cancer using 213Bi-labeled-plasminogen activator inhibitor type 2', EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 28, pp. 1191 - 1191, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000170528300888&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Allen BJ; Rizvi S; Li Y; Tian Z; Ranson M, 2001, 'In vitro and preclinical targeted alpha therapy for melanoma, breast, prostate and colorectal cancers', Critical Reviews in Oncology/Hematology, 39, pp. 139 - 146, http://dx.doi.org/10.1016/S1040-8428(01)00113-5

Li Y; Li L; Wadley RB; Reddel SW; Qi JC; Archis CA; Collins AM; Clarke E; Cooley MA; Kouts S; Naif H; Alali M; Cunningham AL; Wong GW; Stevens RL; Krilis S, 2001, 'Mast cell/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5 and CXCR4', Blood, pp. 3484 - 3490

Li Y; Li L; Wadley R; Reddel S; Qi J; Archis C; Collins A; Clark E; Cooley M; Kouts S; Hassan N; Mohammed A; Cunningham A; Wong G; Stevens R; Krilis S, 2000, 'Identification of a novel population of mast cells/basophils in human periphal blood of allergic patients which is HIV-1 susceptible due to its surface expression of CD4, CCR5, and CXCR4', JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 105, pp. S86 - S87, http://dx.doi.org/10.1016/S0091-6749(00)90690-0

Li L; Li Y; Krilis SA, 1999, 'Monoclonal antibodies recognizing antigens expressed in human mast cells and their progenitors', FASEB JOURNAL, 13, pp. A337 - A337, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000082033301949&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Li L; Li Y; Reddel SW; Cherrian M; Friend DS; Stevens RL; Krilis SA, 1999, 'Cells that have features of both mast cells and basophils in the peripheral blood of allergy, asthma, and drug reactive', JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 103, pp. S43 - S43, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000078509000169&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Li L; Li Y; Krilis SA, 1999, 'Monoclonal antibodies recognizing antigens expressed in human mast cells and their progenitors.', JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 103, pp. S43 - S43, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000078509000170&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wong GW; Tang Y; E F; Sali A; Li L; Li YW; Huang C; Friend DS; Krilis S; Stevens RL, 1999, 'Identification of a new member of the tryptase family of mouse and human mast cell proteases which possesses a novel COOH-terminal hydrophobic extension', The Journal of Biological Chemistry, pp. 30784 - 30793

Back to profile page